#China #Guangzhou #AI Healthcare #Chronic Disease #Pomdoctor Limited

POMDOCTOR LIMITED Boosts AI-Driven Healthcare Strategies

POMDOCTOR LIMITED continues its mission to reshape the healthcare landscape by advancing its healthcare data strategies that leverage AI to manage chronic diseases effectively. Based in Guangzhou, China, the digital healthcare company has made significant strides in utilizing real-world data (RWD) alongside other cutting-edge technologies to provide tailored healthcare solutions.

Advancing Healthcare with Real-World Data

As the digital transformation accelerates in global healthcare systems, the relevance of RWD has significantly increased. Unlike traditional clinical data, RWD is generated from everyday healthcare interactions, enabling more profound insights into patient behaviors, disease progression, and the health management needs over time. According to industry projections, the RWD market is expected to explode from $2.15 billion in 2026 to about $7.11 billion by 2035, growing at a compound annual growth rate (CAGR) of 14.23%.

Major drivers for this growth include greater integration of RWD into clinical research, increased reliance on telehealth, and advancements in wearable technologies and IoT health devices. Another analysis forecasts similar trends, predicting a rise from $2.73 billion to $7.08 billion by 2033, driven by the demand for personalized medicine and improved chronic disease management.

Creating a Robust Healthcare Data Ecosystem

POMDOCTOR LIMITED is actively building a comprehensive healthcare data ecosystem designed for enhancing AI-driven chronic disease management. This framework aggregates a formidable range of RWD sources — data from wearable devices, remote patient monitoring systems, physician interactions, and even payment-related insights. The aim is to establish a continuous feedback loop that not only improves AI analytics but also facilitates the development of deeper, personalized healthcare solutions.

Pomdoctor's leadership recognizes that high-quality healthcare data is pivotal for the future of AI in healthcare. As more interactions occur within this ecosystem, continuous real-world insights will refine AI models, boost health risk analysis, and significantly improve long-term chronic disease management strategies.

Vision from Leadership

Mr. Zhenyang Shi, Chairman and CEO of Pomdoctor, emphasizes the necessity of quality data, stating, "As AI continues to transform healthcare delivery, the capability to gather, analyze, and apply quality real-world data will be critical for achieving personalized health management solutions."

The organization is not only capitalizing on the extensive data amassed over years but is focused on establishing an integrated ecosystem connecting AI technologies, wearables, remote patient monitoring (RPM), and physician networks. This closed-loop approach aims to continuously enhance the company's AI capabilities, generate valuable real-world insights, and support sustainable innovation.

Future Endeavors

Looking ahead, POMDOCTOR LIMITED plans to further its healthcare data strategy by expanding ecosystem partnerships and enhancing technological capabilities. By doing so, they strive to create a leading predictive healthcare infrastructure that improves health outcomes and adds lasting value for all stakeholders, including patients and healthcare providers.

About POMDOCTOR LIMITED

POMDOCTOR LIMITED (NASDAQ: POM) is committed to revolutionizing healthcare through AI-enabled solutions aimed at delivering more personalized, continuous, data-driven healthcare services. With the backing of an established healthcare platform and physician collaboration, the company is on a transformative trajectory toward developing a comprehensive predictive healthcare infrastructure, ultimately enhancing patient care and service efficiency.

For further details, visit POMDOCTOR's official website.